DEVA HOLDİNG A.Ş. Logo

DEVA HOLDİNG A.Ş.

Develops, produces, and markets human medicines, APIs, and veterinary drugs globally.

DEVA | IS

Overview

Corporate Details

ISIN(s):
TRADEVAW91E2
LEI:
959800K5PD9GB1EHW234
Country:
Spain
Address:
AVDA CANTABRIA S / N, 28660 Boadilla del Monte

Description

Established in 1958, DEVA Holding A.Ş. is a pharmaceutical company focused on the development, production, and marketing of medicinal products for human use and active pharmaceutical ingredients (APIs). The company also produces veterinary drugs. DEVA Holding maintains a diverse product portfolio, which includes antineoplastic and immunomodulating agents, and makes its products available on a global scale. Its international business operations are managed through various models, including distributorships, out-licensing, and direct supply agreements.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2010-04-09 18:33
Faaliyet Raporu (Haziran 2016 öncesi)
Turkish 270.9 KB
2010-04-09 18:33
Faaliyet Raporu (Haziran 2016 öncesi)
Turkish 233.6 KB
2010-04-09 18:33
Faaliyet Raporu (Haziran 2016 öncesi)
Turkish 112.7 KB
2010-04-09 18:33
Faaliyet Raporu (Haziran 2016 öncesi)
Turkish 2.5 KB
2010-04-09 08:41
Notification Regarding Dividend Payment
Turkish 67.7 KB
2010-04-09 08:41
Notification Regarding Dividend Payment
Turkish 9.6 KB
2010-04-08 20:55
Sorumluluk Beyanı (Haziran 2016 öncesi)
Turkish 5.0 KB
2010-04-08 20:54
Faaliyet Raporu (Haziran 2016 öncesi)
Turkish 421.0 KB
2010-04-08 20:54
Faaliyet Raporu (Haziran 2016 öncesi)
Turkish 270.9 KB
2010-04-08 20:54
Faaliyet Raporu (Haziran 2016 öncesi)
Turkish 112.7 KB
2010-04-08 20:54
Faaliyet Raporu (Haziran 2016 öncesi)
Turkish 265.0 KB
2010-04-08 20:54
Faaliyet Raporu (Haziran 2016 öncesi)
Turkish 2.1 KB
2010-04-08 20:48
Balance Sheet
Turkish 2.4 MB
2010-04-08 20:48
Balance Sheet
Turkish 33.4 KB
2010-04-08 20:48
Income Statement
Turkish 2.4 MB

Automate Your Workflow. Get a real-time feed of all DEVA HOLDİNG A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DEVA HOLDİNG A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DEVA HOLDİNG A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.